Annex

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

1. (1)

   in the sixth column, expiration of approval, of row 309, Haloxyfop-P, the date is replaced by ‘31 December 2023’;

2. (2)

   in the sixth column, expiration of approval, of row 310, Napropamide, the date is replaced by ‘31 December 2023’;

3. (3)

   in the sixth column, expiration of approval, of row 318, Bromuconazole, the date is replaced by ‘31 January 2024’;

4. (4)

   in the sixth column, expiration of approval, of row 320, Buprofezin, the date is replaced by ‘31 January 2023’.